| Financial Year |
March 31 2023 |
| Monetary Funds |
1,242,747,863.10 |
| Held-for-trading Financial Assets |
1,541,373.24 |
| Notes Receivable |
-- |
| Accounts Receivable |
106,227,100.14 |
| Advances to Suppliers |
21,509,517.77 |
| Other Receivables |
30,070,383.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
177,040,326.87 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
104,516,020.76 |
| Other Current Assets |
354,475,633.35 |
| Total Current Assets |
2,038,128,218.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
58,586,718.35 |
| Investment Properties |
912,040.80 |
| Fixed Assetes |
518,139,695.16 |
| Under-construction Projects |
34,222,394.55 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
95,625,021.36 |
| R&D expenses |
-- |
| Goodwill |
524,488.05 |
| Long-Term Deferred and Prepaid Expenses |
5,921,718.82 |
| Deferred Income Tax Assets |
40,304,284.81 |
| Other Non-Current Assets |
345,870,914.10 |
| Sub-Total of Non-Current Assets |
1,221,602,411.38 |
| Total Assets |
3,259,730,630.27 |
| Short-Term Loans |
262,015,396.97 |
| Trading Financial liabilities |
448,780.00 |
| Notes Payable |
-- |
| Accounts Payable |
289,390,408.25 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
20,974,272.64 |
| Taxes Payable |
12,701,418.38 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
51,529,284.52 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
1,335,766.99 |
| Sub-Total of Current Liabilities |
672,223,607.75 |
| Long-term Loans |
-- |
| Bonds Payable |
610,110,785.38 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
37,054,847.96 |
| Deferred Income Tax Liabilities |
5,472,213.32 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
679,835,717.44 |
| Total Liabilities |
1,352,059,325.19 |
| Paid-In Capital(Or Share Stock) |
139,973,899.00 |
| Capital Surplus |
701,501,287.20 |
| Surplus Reserve |
70,000,000.00 |
| LESS:Treasury Stock |
117,836,041.25 |
| Undistributed Profits |
1,071,854,782.10 |
| Minority Stockholder's Interest |
4,052,489.79 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,903,618,815.29 |
| Owner's Equity（Stockholder's Equity） |
1,907,671,305.08 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,259,730,630.27 |
